Semaglutide belongs to a group of medications called glucagon-like peptide-1 receptor agonists (GLP1-RAs)
These medications dramatically reduce hunger, but they dont replace the fundamentals: adequate protein, hydration, fiber, movement and strength training
Endocrine (2015) 48:75675
So we've seen Humira biosimilars come out and the big PBMs have done their own version of the biosimilar where we have a product called Yusimry, which is only $594 a month, which is cheaper than the cheapest biosimilar that the big three are selling
GraphPad Prism 7.0 software was used to assess the differences between the experimental groups
Some plans designate Zepbound as the preferred GLP-1 for weight loss, which may result in lower copays or easier prior authorization approval